Evaluation of Residual Disease in B-Cell Chronic Lymphocytic Leukemia Patients in Clinical and Bone-Marrow Remission Using CD5-CD19 Markers and PCR Study of Gene Rearrangements

References

• French Cooperative Group on chronic lymphocytic leukemia. Prognostic and therapeutic advances in chronic lymphocytic leukemia management: the experience of the French Cooperative Group. Seminars in Hematology 1987; 24: 275–90
   PubMed Web of Science ®Google Scholar
• Rai K., Sawitsky A., Cronkite E., Chanana A. B., Leey R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–34
   PubMed Web of Science ®Google Scholar
• Binet J. L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M. T., Montconduit M. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• International Workshop on chronic lymphocytic leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging and response criteria. Annals of Internal Medicine 1989; 110: 236–8
   PubMed Web of Science ®Google Scholar
• Cheson B., Bennett J., Rai K., Grever M., Kay N., Schiffer C., Oken M., Keating M., Boldt D., Kempin S., Foon K. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the NCI sponsored working group. Am. J. of Hematol. 1988; 29: 152–63
   PubMed Web of Science ®Google Scholar
• Ault K. A. Detection of small numbers of monoclonal B lymphocytes in the blood of patients with lymphoma. New England Journal of Medicine 1979; 300: 1401–5
   PubMed Web of Science ®Google Scholar
• Berliner N., Ault K. A., Martin P., Weinberg D. S. Detection of clonal excess in lymphoproliferative disease by alfa/lambda analysis: Correlation with immunoglobulin gene DNA rearrangement. Blood 1986; 67: 80–85
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Hierarchy of immunoglobin gene rearrangement in B-cell leukemias. In: Waldmann, T. A., moderator. Molecular genetic analysis of human lymphoid neoplasm: Immunoglobulin genes and c-myc oncogene. Annals of Internal Medicine 1985; 102: 497–510
   PubMedGoogle Scholar
• Brugiatelli M., Callea V., Morabito M., Oliva B., DiCelle P. F., Fiero M. T., Neri A., Foa R. Immunologic and molecular evaluation of residual disease in B cell chronic lymphocytic leukemia patients in clinical remission state. Cancer 1989; 63: 1979–84
   PubMed Web of Science ®Google Scholar
• French Cooperative Group on CLL. Benefit of the CHOP regimen in advanced untreated CLL: Results from a randomized clinical trial. Lancet 1986; i.: 134–649
   Google Scholar
• French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial in 612 patients. Blood 1990; 70: 141–421
   Google Scholar
• French Cooperative Group on Chronic Lymphocytic Leukemia. A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. Blood 1990; 75: 142–225
   Google Scholar
• French Cooperative Group on CLL. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. Nouvelle Revue Francaise d'Hematologie 1988; 30: 44–952
   Google Scholar
• Vuillier F., Tortevoye P., Binet J. L., Dighiero G. CD4, CD8 and NK subsets in B-CLL. Nouvelle Revue Francaise d'Hematologie 1988; 30: 331–4
   PubMedGoogle Scholar
• Trainor K. J., Brisco M. J., Story C. J., Morley A. A. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990; 75: 2220–22
   PubMed Web of Science ®Google Scholar
• Brisco M. J., Tan L. W., Orsborn A. M., Morley A. A. Development of a highly sensitive assay, based on the polymerase chain reaction, for various B-lymphocyte clones in a polyclonal population. British Journal of Haematology 1990; 75: 163–7
   PubMed Web of Science ®Google Scholar
• Vandenvelde C., Scheen R., Fondu P., Van Beers D. Fast PCR, based quantitative detection of B-cell malignancies. Nouvelle Revue Francaise d'Hematologie 1991, (in press)
   Google Scholar
• Ravetch J. V., Siebenlist U., Korsmeyer S., Waldmann J., Leder P. Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583–91
   PubMed Web of Science ®Google Scholar
• Sambrook J., Frizsh E. F., Maniatis T. Molecular cloning: a laboratory manual, 2nd edition. Cold Spring Harbor Press. 1989
   Google Scholar
• Vuillier F., Scott-Algara D., Dighiero G. Extensive analysis of lymphocyte subsets in normal subjects by three-color immunofluorescence. Nouvelle Revue Francaise d'Hematologie 1991; 33: 31–38
   PubMedGoogle Scholar
• Grever M. R., Kopecky K. J., Coltman C. A., Files J. C., Greenberg B. R., Hutton J. J., Talley R., Von Hoff D. D., Balcerzak S. P. Fludrabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia. Nouvelle Revue Francaise d'Hematologie 1988; 30: 457–59
   PubMedGoogle Scholar
• Keating M. J., Kantarjian M., Redman J., Koller C., Barlogie B., Velasquez W., Plunket W., Freireich E. J., McCredie K. B. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19–25
   PubMed Web of Science ®Google Scholar
• Dillman R. O., Mick R., McLntyre O. K. Pentostatin in chronic lymphocytic leukemia: a phase II trial of cancer and leukemia group. British Journal of Clinical Oncology 1989; 7: 433–38
   PubMed Web of Science ®Google Scholar
• Piro L. D., Carrera C. J., Beutler E., Carson D. A. Chorodeoxyadenosin: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988; 72: 1069–73
   PubMed Web of Science ®Google Scholar
• Michallet M., Corront B., Gratwohl A., Milpied N., Dauriac C., Brunet S., Soler J., Jouet J. P., Esperou Bourdeau H., Arcese W., Witz F., Moine A., Zwaan F. E. Allogenic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Leukemia and Lymphoma 1991; 5(suppl 1)127–132
   PubMed Web of Science ®Google Scholar
• Wormsley S. B., Rai K. R., Gale R. P. Analysis of treatment response in chronic lymphocytic leukemia: new approaches. Nouvelle Revue Francaise d'Hematologie 1988; 30: 413–7
   PubMedGoogle Scholar
• Kipps T. J., Herzenberg L. A., Vaughan J. H. Genetic influence on the levels of circulating Leu-1 B lymphocytes. Blood 1986; 68(suppl. 1)97, (abstr.)
   Google Scholar
• Yamada M., Wasserman R., Lange B., Reichard B. A., Womer R. B., Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment. New England Journal of Medicine 1990; 323: 448–55
   PubMed Web of Science ®Google Scholar
• Robertson L. E., Huh Y., Hirsch-Ginsberg C., Kantarjian H., O'Brien S., Koller C., McCredie K. B., Keating M. J. Clinical, immunophenotypic and molecular analysis of the complete response in chronic lymphocytic leukemia. Blood 1990; 76 (suppl): 314a, (abstr)
   Google Scholar